DiagnaMed Announces LIFE Offering of up to $650,000
May 15, 2024 18:10 ET
|
DiagnaMed Holdings Corp.
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is...
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Targeting Multi-Billion Digital Brain Health Market
May 15, 2024 08:00 ET
|
DiagnaMed Holdings Corp.
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is...
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper
April 25, 2024 08:00 ET
|
DiagnaMed Holdings Corp.
TORONTO, April 25, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI,...
DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI
April 23, 2024 08:00 ET
|
DiagnaMed Holdings Corp.
Clinics can apply at BrainAge.ca TORONTO, April 23, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company...
DiagnaMed Adds New Launch Site of CERVAI™ Brain Health AI
April 03, 2024 09:00 ET
|
DiagnaMed Holdings Corp.
TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, today announced...
DiagnaMed Announces BRAIN AGE® Trademark Registration Approved by CIPO
March 20, 2024 08:00 ET
|
DiagnaMed Holdings Corp.
TORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, announced its...
DiagnaMed Strengthening Intellectual Property Support for CERVAI™ Brain Health AI Solution
March 14, 2024 08:00 ET
|
DiagnaMed Holdings Corp.
TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, is pleased to...
DiagnaMed Accelerates Commercialization Initiatives of CERVAI™ Brain Health AI Solution
March 11, 2024 08:00 ET
|
DiagnaMed Holdings Corp.
TORONTO, March 11, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, is pleased to...
DiagnaMed Announces Test Launch of CERVAI™ Brain Health in University Brain Health Center
February 28, 2024 07:30 ET
|
DiagnaMed Holdings Corp.
TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a digital health artificial intelligence company focused on brain...
DiagnaMed Announces Pilot Launch of CERVAI™ Brain Health AI Solution
January 17, 2024 07:30 ET
|
DiagnaMed Holdings Corp.
TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a digital health artificial intelligence company focused on brain...